| Document Date: 2009-10-03 17:24:05
Open Document File Size: 2,91 MBShare Result on Facebook
City Technology Square Cambridge / Cambridge / / Company Novartis Group / Novartis Vaccines and Diagnostics / Novartis Molecular Diagnostics / Novartis Venture Funds / / Country United States / / Event Product Issues / Company Expansion / / Facility Square Cambridge / / IndustryTerm biotechnology hub / pharmaceutical research arm / diagnostics tools / treatment of untractable diseases / healthcare environment / pharmaceutical discovery / chemical-based approach / biotechnology / treatment of life-threatening diseases / chemical and biological sciences / biotechnology research culture / healthcare products / healthcare solutions / biotechnology-based medicines / pharmaceutical / pharmaceutical research organization / large pharmaceutical partners / antibody technology / / MedicalCondition disease / musculoskeletal disorders / diabetes / untractable diseases / diseases / infectious diseases / human disease / / Product Simulect / Proleukin / Sandostatin / Lucentis / Miacalcin / Xolair / proteins / / ProvinceOrState Massachusetts / / Technology bioinformatics / antibody technology / diagnostic tests / antibodies / biotechnology / 200 Technology / 200/500 Technology / human genome / / URL http /
SocialTag |
Novartis in Massachusetts 2 | Novartis in Massachusetts Novartis Biologics